Effectiveness and Safety of Xiaoshuanchangrong (XSCR) Capsule for the Treatment of Patients Who Have Suffered From a Stroke

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

This study will determine if Xiaoshuanchangrong (XSCR) capsule will improve recovery from an acute stroke. The study is designed to look at both overall recovery and recovery of motor function, for example muscle strength and coordination.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Fudan University
• Collaborator: Sizuo

Criteria

Inclusion Criteria:

• Acute ischemic stroke with limb weakness, NIH stroke scale ≥6, limb weakness score ≥2

• Onset of symptoms within 72 hours

• 18 Years and older

• Consistent with the Qi deficiency and Blood stasis type by Traditional Chinese Medicine (TCM) standard

• Patients or their representatives voluntarily take part in this study and signed the informed consent

Exclusion Criteria:

• Transient ischemic attack(TIA), cerebral hemorrhage, subarachnoid hemorrhage

• Subjects who are unlikely to complete taking the investigational product and/or are unlikely to undergo active medical management during that period due to a severe clinical condition.

• Pregnant or breast-feeding.

• Proven disability by law, such as blindness, deafness, dumb, disturbance of intelligence, mental disorders, limb handicap.

• Liable to be allergic (allergic to at lease 2 foods/drugs previously exposed)

• Had been participated in other clinical trials during the last 1 month prior to study inclusion.